BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20663890)

  • 21. Structure-function studies of T-cell receptor-superantigen interactions.
    Li H; Llera A; Mariuzza RA
    Immunol Rev; 1998 Jun; 163():177-86. PubMed ID: 9700510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response during tumor therapy with antibody-superantigen fusion proteins.
    Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M
    Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced T cell expansion by a superantigen as a result of impaired B cell development in mice deficient for the p85alpha regulatory subunit of PI3K.
    Arimura Y; Ezaki T; Koyanagi M; Uchiyama T; Koyasu S; Yagi J
    J Leukoc Biol; 2010 Mar; 87(3):493-500. PubMed ID: 20007249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the energy of superantigen Staphylococcus enterotoxin C3 recognition of an alpha/beta T cell receptor using alanine scanning mutagenesis.
    Churchill HR; Andersen PS; Parke EA; Mariuzza RA; Kranz DM
    J Exp Med; 2000 Mar; 191(5):835-46. PubMed ID: 10704464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine Vbeta3+ and Vbeta7+ T cell subsets are specific targets for the HERV-K18 Env superantigen.
    Tai AK; Lin M; Chang F; Chen G; Hsiao F; Sutkowski N; Huber BT
    J Immunol; 2006 Sep; 177(5):3178-84. PubMed ID: 16920956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.
    Stohl W; Xu D; Zang S; Kim KS; Li L; Hanson JA; Stohlman SA; David CS; Jacob CO
    Int Immunol; 2001 Oct; 13(10):1291-300. PubMed ID: 11581174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The alpha beta T cell receptor clustering upon superantigen/MHC recognition.
    Mazda O; Satoh E; Imanishi J
    Scand J Immunol; 1997 Sep; 46(3):262-7. PubMed ID: 9315114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity.
    Noël C; Florquin S; Goldman M; Braun MY
    Int Immunol; 2001 Apr; 13(4):431-9. PubMed ID: 11282982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superantigens anergize cytokine production but not cytotoxicity in vivo.
    Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
    Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.
    Cauley LS; Miller EE; Yen M; Swain SL
    J Immunol; 2000 Dec; 165(11):6056-66. PubMed ID: 11086037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness--a model for non-allergic asthma.
    Herz U; Rückert R; Wollenhaupt K; Tschernig T; Neuhaus-Steinmetz U; Pabst R; Renz H
    Eur J Immunol; 1999 Mar; 29(3):1021-31. PubMed ID: 10092107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effects of a bacterial superantigen on macaque TCR repertoires.
    Kou ZC; Halloran M; Lee-Parritz D; Shen L; Simon M; Sehgal PK; Shen Y; Chen ZW
    J Immunol; 1998 May; 160(10):5170-80. PubMed ID: 9590270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the TCR Vbeta binding sites in the superantigen staphylococcal enterotoxin D].
    Li YF; Zhong L; Zhu XH; Zhu XH; Yang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):757-9. PubMed ID: 15555455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
    Maillard I; Xenarios I; Diggelmann H; Orbea HA
    Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
    Hong SC; Waterbury G; Janeway CA
    J Exp Med; 1996 Apr; 183(4):1437-46. PubMed ID: 8666902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK; Hwang LA; Hui KM
    Cell Immunol; 1994 Oct; 158(1):83-95. PubMed ID: 7916268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell receptor V alpha 4 is expressed by a subpopulation of V beta 6 T cells that respond to the bacterial superantigen staphylococcal enterotoxin B.
    Borrero H; Donson D; Cervera C; Rexer C; Macphail S
    J Immunol; 1995 May; 154(9):4247-60. PubMed ID: 7722285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.